Mexico and the United States cannot pursue diverging policies on marijuana legalization, Mexican President Enrique Pena Nieto was quoted as saying, hinting he may be open to following the lead taken by some U.S. states in changing drug laws. Political pressure has grown in Mexico to take a more liberal stance on marijuana. In an interview with Spanish newspaper El Pais, Pena Nieto said "we can't continue on this road of inconsistency between the legalization we've had [...] in the most important consumer market, the United States, and in Mexico where we continue to criminalize production of marijuana."
An Organization of American States study in response to calls by some Latin American leaders for rethinking the war on drugs advocates serious discussion of legalizing marijuana. “Sooner or later decisions in this area will need to be taken,” the study says, although it no proposals or specific recommendations on any issue are made. The $2.2 million study was hailed as historic by drug policy reform advocates who call the more than $20 billion that Washington has spent on counterdrug efforts in Latin America over the past decade a damaging waste of taxpayer money.
Latin American drug policies have made no dent in the drug trade; instead they have taken a tremendous toll on human lives. In 2009, the Washington Office on Latin America (WOLA) and the Transnational Institute (TNI) embarked on an ambitious project to document the real impact of Latin America’s “war on drugs” and to show its human cost through the video testimonies of the victims themselves.
By Sara Miller Llana, Staff writer, Sebastian Scholl , Sara Shahriari, Latin America correspondent
29 July 2012
Like thousands of other Bolivians, Marcela Lopez Vasquez's parents migrated to the Chapare region, in the Andean tropics, desperate to make a living after waves of economic and environmental upheaval hit farming and mining communities in the 1970s and '80s.
Remarkable drug policy developments are taking place in Latin America. This is not only at the level of political debate, but is also reflected in actual legislative changes in a number of countries. All in all there is an undeniable regional trend of moving away from the ‘war on drugs’. This briefing explains the background to the opening of the drug policy debate in the region, summarises the most relevant aspects of the ongoing drug law reforms in some countries, and makes a series of recommendations that could help to move the debate forward in a productive manner.
After decades of war with drug cartels, Latin America faces sickening levels of violence and corruption that have spread throughout the region. At a summit meeting of Western Hemisphere leaders in Cartagena, Colombia, last month, several leaders urged that there be a wide-ranging discussion that even considered drug legalization as an alternative to the militarized war on drugs. Is it it time for Latin America and the United States to abandon the war on drugs and deal with the issue as a matter of public health rather than combat? See: Stop Following a Failed Policy, by Otto Pérez Molina, president of Guatemala.
The startling, unprogrammed, and rebellious discussion about drugs that took place among hemispheric leaders in April at a summit in Cartagena, Colombia, barely mentioned addiction, because it’s too late for that. The discussion that for the first time in forty years challenged the United States’ dominance on drug issues focused urgently instead on the ways that the financial health, political stability, and national security of virtually every country in the Americas has been undermined by the drug trade.
When the recent Summit of the Americas in Colombia decided to commission a study on whether to decriminalize drugs, many thought that would be the end of it, and the whole thing would be quickly forgotten. Well, maybe not. For starters, it was the first time that such a large group of heads of state ventured into that once taboo area. And there are several other non-related factors that may contribute to put decriminalization in the front burner later this year, or in early 2013
At the recent Summit of the Americas, Latin America's leaders pressed Prime Minister Stephen Harper and U.S. President Barack Obama to study alternatives to the failed war on drugs; even Mr. Harper, architect of mandatory minimums for minor drug offences at home, acknowledged the current approach isn't working. The 31 hemispheric leaders agreed to appoint a panel to study reform of global drug policies. The panel could spare itself the trouble and endorse the groundbreaking report of a blue-ribbon Global Commission on Drug Policy.
The most important story of the Summit of the Americas was the Latin American demand to open the debate on an alternative to the ‘war on drugs’. The emergence of an increasingly independent and assertive Latin America insisting on a change of direction on drugs reflects an important shift in the terms of the relationship with the United States. Clamor for “democratization” of the debate and a search for new alternatives stems from the perception that Latin American societies pay a disproportionate price in lost lives, hijacked justice systems, abuses in overcrowded prisons, and displaced small farmers, because of the U.S.-led strategy that has prioritized stemming the supply of drugs over reducing its own demand.
At the Summit of the Americas, Prime Minister Stephen Harper expressed doubt about the war on drugs. “I think what everybody believes and agrees with, and to be frank myself, is that the current approach is not working, but it is not clear what we should do.” It’s admirable for a politician to admit uncertainty. And rare. Especially for a politician who has never expressed anything less than unshakable conviction in the Reaganite nostrums of drug prohibition. But Harper had good reason to be a little shaken.
Present international drug control policies are deeply-rooted and change will no doubt come slowly. However, as a result of the Cartagena summit, for the first time a meaningful debate on developing and implementing drug control policies that are more humane and effective is underway. The genie is out and will be very hard to put back in the bottle, as much as U.S. officials might try.
This weekend’s Summit of the Americas did not produce a joint communiqué charting the future of the hemisphere, but the 31 leaders agreed on one thing: The U.S.-led war on drugs has been a dismal failure. The summit pledged to create a panel of experts through the Organization of American States to consider drug policy reforms, and new approaches to stem the violence and power of the drug cartels. In the words of Guatemalan President Otto Perez, a champion of drug liberalization, it is time to “stop being dumb witnesses to a global deceit” and consider treatment, harm reduction and decriminalization as viable alternatives.
As the hemisphere’s leaders gather in Colombia this week for the VI Summit of the Americas, their on-camera discussions will be dominated by perennial convention topics: poverty, cooperation, the need for roads. But behind closed doors, they are expected to tackle a more contentious issue: the narcotics trade.
At the upcoming Summit of the Americas, President Dilma has an unprecedented opportunity to contribute to building a new architecture for global drug policy. She can make a decisive break with the past. A new approach would emphasize public health, social justice and cultures of peace rather than repression, enforcement and war. If Brazil is to consolidate its international legitimacy and position as promoter of human rights, it needs to adopt more humane policies back home.